Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05940129 · ClinicalTrials.gov registry record · NA

Women and Child, Safety, Health, and Empowerment

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT05940129: Completed NA study, sponsored by Johns Hopkins University.

NCT05940129 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05940129, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

Gender-based violence (GBV) (including homicide) is one of the leading causes of maternal and child (fetus, newborn or infant) mortality and morbidity in limited resource settings such as India. This study is evaluating the feasibility, acceptability and preliminary efficacy of WC-SHE (Women and Children-Safety, Health and Empowerment) intervention developed to promote health and safety outcomes of mother and children in rural and/or tribal regions in India. The aim will be to refine, optimize and standardize the WC-SHE intervention and its added components, develop fidelity measures, conduct a feasibility and acceptability evaluation of the intervention and implementation procedures as well as examine preliminary efficacy outcomes of WC-SHE.

Interventions

  • BEHAVIORAL Women and Child, Safety, Health and Empowerment (WC-SHE)

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-10-21
Est. Completion 2023-11-30
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05940129

The ClinicalTrials.gov registry entry for NCT05940129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Women and Child, Safety, Health and Empowerment (WC-SHE) is the first listed.

NCT05940129 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05940129 about?

NCT05940129 is a clinical study titled "Women and Child, Safety, Health, and Empowerment". Gender-based violence (GBV) (including homicide) is one of the leading causes of maternal and child (fetus, newborn or infant) mortality and morbidity in limited resource settings such as India. This study is evaluating the feasibility, acceptability and preliminary efficacy of WC-SHE (Women and Chi...

What is the current status of trial NCT05940129?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2022-10-21. Estimated completion is 2023-11-30.

What interventions are being tested in trial NCT05940129?

The interventions under investigation include: Women and Child, Safety, Health and Empowerment (WC-SHE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05940129?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.